The eye's view of antigen presentation

Human Immunology

Volumn 63, Issue 6, 2002, Pages 435-443

  Streilein, J Wayne ^a   Masli, Sharmila ^a   Takeuchi, Masaru ^b   Kezuka, Takeshi ^b  

^a SCHEPENS EYE RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Anterior chamber of eye; Antigen presenting cells; Immune privilege; Thrombospondin; Transforming growth factor

Indexed keywords

CD40 ANTIGEN; INTERLEUKIN 12; THROMBOSPONDIN; TRANSFORMING GROWTH FACTOR BETA2; COMPLEMENT; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

ANTERIOR EYE CHAMBER; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; AQUEOUS HUMOR; CELL DIFFERENTIATION; DELAYED HYPERSENSITIVITY; GENE ACTIVATION; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; NATURAL KILLER CELL; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; ANIMAL; ANTIBODY SPECIFICITY; AUTOIMMUNITY; BIOLOGICAL MODEL; CENTRAL NERVOUS SYSTEM; CYTOLOGY; EYE; GENETICS; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; METABOLISM; SPLEEN;

ANIMALS; ANTERIOR CHAMBER; ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; AUTOIMMUNITY; CENTRAL NERVOUS SYSTEM; COMPLEMENT SYSTEM PROTEINS; EYE; IMMUNE TOLERANCE; MODELS, IMMUNOLOGICAL; ORGAN SPECIFICITY; SPLEEN; THROMBOSPONDIN 1; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035985613     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0198-8859(02)00393-2     Document Type: Article

References (55)

1. Actively acquired tolerance to foreign cells
2. T cell co-stimulation and in vivo tolerance
3. Dendritic cells and the control of immunity
4. A second study of the behavior and fate of skin homografts in rabbits
5. Die Entwicklung der in fremden Grund versetzten lebenden Gewebe
6. Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue and to the anterior chamber of the eye
7. Immunologically privileged sites
8. Regional immunity and ocular immune privilege
9. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: A new view
10. Aqueous humor dynamics in monkeys (Macaca irus and Cercopithecus ethiops)
11. Ocular immunosuppressive microenvironment
12. A vision of cell death: Insights into immune privilege
13. Differential expression of the complement regulatory proteins in the human eye
14. Does innate immune privilege exist?
15. Immune regulation and the eye: A dangerous compromise
16. Immune privilege and immune regulation in the eye
17. Commentary: Immune privilege, deviation and regulation in the eye
18. 1 lymphocyte induced immune deviation
19. 1 lymphocyte induced immune deviation
20. Deviant immune responses to allogeneic tumors injected intracamerally and subcutaneously in mice
21. Systemic immune unresponsiveness induced in adult mice by anterior chamber presentation of minor histocompatibility antigens
22. Anterior chamber-associated immune deviation
23. Suppressed cellular immunity in mice harboring intraocular melanomas
24. Failure of infiltrating precursor cytotoxic T cells to acquire direct cytotoxic function in immunologically privileged sites
25. Distinctive humoral responses following anterior chamber and intravenous administration of soluble antigen. Evidence for active suppression of IgG2-secreting B cells
26. Selective and specific inhibition of 24 hour skin reactions in the guinea pig. I. Immune deviation: Description of the phenomenon and the effect of splenectomy
27. Imposing deviant immunity on the presensitized state
28. Anterior chamber associated immune deviation elicited via primate eyes
29. Do immunologically privileged sites require a functioning spleen?
30. Induction of anterior chamber associated immune deviation requires an intact, functional spleen
31. Immunoregulatory properties of bone marrow derived cells in the iris and ciliary body
32. Functional studies of major histocompatibility class II positive dendritic cells and resident tissue macrophages isolated from the rat iris
33. Studies on the induction of anterior chamber associated immune deviation (ACAID). 1. Evidence that an antigen-specific, ACAID-inducing cell-associated signal exists in the peripheral blood
34. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
35. MIP-2 recruits NK T cells to the spleen during tolerance induction
36. Role of splenic B cells in the immune privilege of the anterior chamber of the eye
37. CD1d on antigen transporting APCs and splenic marginal zone B cells promote NK T cell-dependent tolerance
38. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T suppressor cell populations
39. Studies on the induction of anterior chamber associated immune deviation (ACAID). II. Eye-derived cells participate in generating blood-borne signals that induce ACAID
40. Fluids from immune privileged sites endow macrophages with the capacity to induce antigen-specific immune deviation via mechanisms involving transforming growth factor-beta
41. Studies on the induction of anterior chamber associated immune deviation (ACAID). III. Induction of ACAID depends upon intraocular transforming growth factor-beta
42. Evidence that peritoneal exudate cells cultured with eye-derived fluids are the proximate antigen-presenting cells in immune deviation of the ocular type
43. On the mechanisms by which TGFβ 2 alters antigen presenting abilities of macrophages on T cell activation
44. TGFβ promotes immune deviation by altering accessory signals of antigen presenting cells
45. Analysis of in vivo regulatory properties of T cells activated in vitro by TGFβ-2-treated antigen presenting cells
46. In vitro generation of regulatory CD8+ T cells similar to those found in mice with anterior chamber associated immune deviation
47. Functional analysis of macrophage hybridomas. I. Production and initial characterization
48. Analysis of an in vitro generated signal that induces systemic immune deviation similar to that elicited by antigen injected into the anterior chamber of the eye
49. Expression of thrombospondin in TGFβ-treated antigen presenting cells and its relevance to their immune deviation-promoting properties
50. The functions of thrombospondin-1 and -2
51. A human fibrosarcoma inhibits systemic angiogenesis and the growth of experimental metastases via thrombospondin-1
52. Production and accumulation of thrombospondin-1 in human retinal pigment epithelial cells
53. Thrombospondin-1, a natural inhibitor of angiogenesis, is present in vitreous and aqueous humor and is modulated by hyperglycemia
54. Thrombospondin-1 inhibits TCR-mediated T lymphocyte early activation